Predicting breast cancer therapeutic response
Nat Med
.
2018 May;24(5):535-537.
doi: 10.1038/s41591-018-0033-7.
Authors
Ana C Garrido-Castro
1
,
Eric P Winer
2
Affiliations
1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eric_winer@dfci.harvard.edu.
PMID:
29736021
DOI:
10.1038/s41591-018-0033-7
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms*
Carboplatin
Humans
Trinitrotoluene*
Triple Negative Breast Neoplasms*
Substances
Trinitrotoluene
Carboplatin